Suchergebnisse - "EC 3.2.2.6"

PubPharm (3.279)

1

Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy

enthalten in: British journal of haematology | 2024

von Venglar, O. | Kapustova, V. | Anilkumar Sithara, A. | +16

2

CD38 expression by plasma cells in extramedullary multiple myeloma

enthalten in: Haematologica | 2024

von Notarfranchi, L. | Accardi, F. | Mancini, C. | +15

3

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

4

Retention of stress susceptibility in the mdx mouse model of Duchenne muscular dystrophy after PGC-1α overexpression or ablation of IDO1 or CD38

enthalten in: Human molecular genetics | 2024

von Johnson, E. | Southern, W. | Doud, B. | +4

5

Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases

enthalten in: Protein science : a publication of the Protein Society | 2024

von Kim, H. | Hariri, K. | Zhang, X. | +5

6

Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity

enthalten in: Cardiovascular research | 2024

von Peclat, T. | Agorrody, G. | Colman, L. | +11

7

Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies

enthalten in: Cancer research communications | 2024

von Keller, A. | Reiman, L. | Perez de Acha, O. | +7

8

CD38 promotes hematopoietic stem cell dormancy

enthalten in: PLoS biology | 2024

von Ibneeva, L. | Singh, S. | Sinha, A. | +17

9

Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment

enthalten in: Pharmacological research | 2024

von Liu, Y. | Zhang, L. | Wang, L. | +10

10

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

enthalten in: Nature communications | 2024

von Liu, J. | Xing, L. | Li, J. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[328]